Codexis (CDXS) Other Operating Expenses (2010 - 2026)
Codexis (CDXS) posted quarterly Other Operating Expenses of $2.1 million for Q1 2026, down 24.45% year-over-year from $2.7 million in Q1 2025, and down 62.13% quarter-over-quarter from $5.4 million in Q4 2025.
Codexis (CDXS) Other Operating Expenses (2010 - 2026) Analysis & Trends
Codexis' Other Operating Expenses history runs 17 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 24.45% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $12.1 million (down 15.72% YoY), while the FY2025 annual figure was $9.3 million, down 43.24% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $2.1 million, down from $5.4 million in the prior quarter.
- The five-year high for Other Operating Expenses was $12.2 million in Q3 2023, with the low at $2.1 million in Q1 2026.
- The 5-year median for Other Operating Expenses is $4.3 million (2024), against an average of $5.4 million.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses jumped 161.0% in 2022, then plunged 71.8% in 2023.
- Codexis' Other Operating Expenses stood at $8.5 million in 2022, then sank by 66.15% to $2.9 million in 2023, then grew by 27.67% to $3.7 million in 2024, then soared by 49.15% to $5.4 million in 2025, then plunged by 62.13% to $2.1 million in 2026.
- Business Quant data shows CDXS's Other Operating Expenses at $2.1 million in Q1 2026, $5.4 million in Q4 2025, and $2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.51 Mn |
| Mar 31, 2026 | 2.06 Mn |
| Dec 31, 2025 | 5.45 Mn |
| Sep 30, 2025 | 2.47 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.73 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Sep 30, 2024 | 4.32 Mn |
| Jun 30, 2024 | 3.63 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Dec 31, 2023 | 2.86 Mn |
| Sep 30, 2023 | 12.23 Mn |
| Jun 30, 2023 | 3.18 Mn |
| Mar 31, 2023 | 4.52 Mn |
| Dec 31, 2022 | 8.46 Mn |
| Sep 30, 2022 | 9.79 Mn |
| Jun 30, 2022 | 11.27 Mn |
| Mar 31, 2022 | 8.52 Mn |
| Dec 31, 2021 | 6.81 Mn |
| Sep 30, 2021 | 6.87 Mn |